Never Run Out Of Buyers To Sell To.
20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs by leveraging high-throughput screening and computing to generate peptide drugs with desired biophysical, functional, and pharmacological properties.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.